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Abstract
Background: Knowledge of the number of deaths caused by risk factors is needed for health policy and priority setting. Our
aim was to estimate the mortality effects of the following 12 modifiable dietary, lifestyle, and metabolic risk factors in the
United States (US) using consistent and comparable methods: high blood glucose, low-density lipoprotein (LDL) cholesterol,
and blood pressure; overweight–obesity; high dietary trans fatty acids and salt; low dietary polyunsaturated fatty acids,
omega-3 fatty acids (seafood), and fruits and vegetables; physical inactivity; alcohol use; and tobacco smoking.
Methods and Findings: We used data on risk factor exposures in the US population from nationally representative health
surveys and disease-specific mortality statistics from the National Center for Health Statistics. We obtained the etiological
effects of risk factors on disease-specific mortality, by age, from systematic reviews and meta-analyses of epidemiological
studies that had adjusted (i) for major potential confounders, and (ii) where possible for regression dilution bias. We
estimated the number of disease-specific deaths attributable to all non-optimal levels of each risk factor exposure, by age
and sex. In 2005, tobacco smoking and high blood pressure were responsible for an estimated 467,000 (95% confidence
interval [CI] 436,000–500,000) and 395,000 (372,000–414,000) deaths, accounting for about one in five or six deaths in US
adults. Overweight–obesity (216,000; 188,000–237,000) and physical inactivity (191,000; 164,000–222,000) were each
responsible for nearly 1 in 10 deaths. High dietary salt (102,000; 97,000–107,000), low dietary omega-3 fatty acids (84,000;
72,000–96,000), and high dietary trans fatty acids (82,000; 63,000–97,000) were the dietary risks with the largest mortality
effects. Although 26,000 (23,000–40,000) deaths from ischemic heart disease, ischemic stroke, and diabetes were averted by
current alcohol use, they were outweighed by 90,000 (88,000–94,000) deaths from other cardiovascular diseases, cancers,
liver cirrhosis, pancreatitis, alcohol use disorders, road traffic and other injuries, and violence.
Conclusions: Smoking and high blood pressure, which both have effective interventions, are responsible for the largest
number of deaths in the US. Other dietary, lifestyle, and metabolic risk factors for chronic diseases also cause a substantial
number of deaths in the US.
Please see later in the article for the Editors’ Summary.
Citation: Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, et al. (2009) The Preventable Causes of Death in the United States: Comparative Risk Assessment of
Dietary, Lifestyle, and Metabolic Risk Factors. PLoS Med 6(4): e1000058. doi:10.1371/journal.pmed.1000058
Academic Editor: Simon Hales, University of Otago, New Zealand
Received September 17, 2008; Accepted February 20, 2009; Published April 28, 2009
Copyright:  2009 Danaei et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by a cooperative agreement from the Centers for Disease Control and Prevention (CDC) through the Association of
Schools of Public Health (ASPH) (Grant No. U36/CCU300430-23). The contents of this article are solely the responsibility of the authors and do not necessarily
represent the official views of CDC or ASPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The Academic Editor declares that he had no competing interests when the first version of this paper was submitted. After a revised
version was submitted, he started working on the global burden of disease from climate change project at the WHO in Geneva. Majid Ezzati is also working on the
Global Burden of Disease project.
Abbreviations: BAC, blood alcohol concentration; BMI, body mass index; CI, confidence interval; FARS, Fatality Analysis Reporting System; FPG, fasting plasma
glucose; HDL, high-density lipoprotein; ICD, International Classification of Diseases; IHD, ischemic heart disease; LDL, low-density lipoprotein; NCHS, National
Center for Health Statistics; NESARC, National Epidemiologic Survey on Alcohol and Related Conditions; NHANES, National Health and Nutrition Examination
Survey; OR, odds ratio; PAF, population attributable fraction; PUFA, polyunsaturated fatty acids; RR, relative risk; SBP, systolic blood pressure; SD, standard
deviation; SFA, saturated fatty acids; TMRED, theoretical-minimum-risk exposure distribution.
* E-mail: majid_ezzati@harvard.edu
PLoS Medicine | www.plosmedicine.org 1 April 2009 | Volume 6 | Issue 4 | e1000058Introduction
Valid and comparable information on mortality caused by
diseases, injuries, and their modifiable risk factors is important for
health policy and priority setting [1,2]. The standard death
certificate is valuable for assigning deaths to specific diseases or
injuries, but does not provide information on the modifiable risk
factors that cause these diseases. Previous research has indicated
that modifiable risk factors are responsible for a large number of
premature deaths in the United States [1,3]. However, prior
analyses did not use consistent and comparable methods for the
mortality effects of different risk factors. More importantly,
previous analyses did not include any dietary risk factors. The
only metabolic risk factor—i.e., those measured by physiological
indicators such as blood pressure, blood glucose, serum cholester-
ol, and body mass index (BMI)—in these analyses was overweight–
obesity.
We estimated the number of deaths attributable to major
dietary, lifestyle, and metabolic risk factors in the US using
consistent, comparable, and current definitions, methods, and data
sources. We conducted the analysis in the US because the results
can inform priority-setting decisions for policies and programs that
aim to improve the nation’s health, e.g., Healthy People 2010 and
(the forthcoming) Healthy People 2020. The US also has high-quality
data on disease-specific mortality and on population exposure to a
range of risk factors from nationally representative health
examination and interview surveys. Our results provide, to our
knowledge, the most comprehensive and comparable quantitative
assessment of the mortality burden of important modifiable risk
factors in the US population, and the only one to include the
effects of multiple dietary and metabolic factors.
Methods
We conducted a population-level CRA (comparative risk
assessment) for 12 major modifiable dietary, lifestyle, and
metabolic risks. The CRA analysis estimates the number of deaths
that would be prevented in the period of analysis if current
distributions of risk factor exposure were changed to a hypothetical
alternative distribution. The inputs to the analysis are (1) the
current population distribution of risk factor exposure, (2) the
etiological effect of risk factor exposures on disease-specific
mortality, (3) an alternative exposure distribution, and (4) the
total number of disease-specific deaths in the population.
We also calculated the proportion of the mortality burden of
risk factors among people in specific exposure ranges and
categories that correspond to current clinical and public health
guidelines, e.g., the proportion of deaths attributable to high blood
pressure, that is, among individuals with systolic blood pressure
(SBP) $140 mmHg. This threshold-based analysis helps evaluate
the relative impact of programs that focus on people whose high-
risk status is either undiagnosed or remains uncontrolled after
receiving the currently administered usual care.
Selection of Risk Factors
Among dietary, lifestyle, and metabolic factors, we selected
specific risks that fulfilled the following criteria. (1) Sufficient
evidence was available on the presence and magnitude of likely
causal associations with disease-specific mortality from high-
quality epidemiological studies; (2) available or envisionable
interventions existed to modify exposure to the risk; and (3) data
on risk factor exposure were available from nationally represen-
tative surveys and epidemiological studies without systematic bias.
The 12 major modifiable risk factors selected based on these
criteria are shown in Table 1. High blood pressure and high low-
density lipoprotein (LDL) cholesterol were selected as major
modifiable risk factors for cardiovascular mortality, with their
effects on cardiovascular diseases established in observational as
well as randomized studies. High blood glucose, overweight–
obesity (high BMI), physical inactivity, five dietary factors, alcohol
use, and tobacco smoking were selected as major modifiable risk
factors for cardiovascular diseases, cancers, and other diseases.
The mortality-reducing effects of omega-3 fatty acids and of
replacing saturated fatty acids (SFA) with polyunsaturated fatty
acids (PUFA) (denoted as PUFA and PUFA-SFA replacement
interchangeably hereafter) have been confirmed in randomized
trials. The mortality effects of other risk factors were considered
probable or convincing based on the breadth and consistency of
evidence from well-conducted observational studies. The relation-
ship between dietary salt (sodium) and cardiovascular mortality
was based on convincing effects on blood pressure in intervention
studies, as well as on disease outcomes in at least one study.
Several other important risk factors were considered, but could
not be included because sufficient or unbiased data on their
national exposure distributions and/or effects on disease-specific
mortality were not available, or because the evidence on causal
effects was less convincing. Examples of important risk factors not
included in this work because of insufficient data on exposure or
on the presence and magnitude of causal effects include illicit drug
use, caloric intake, triglycerides and high-density lipoprotein
(HDL) cholesterol, whole-grain intake, gun ownership, and risk
factors that primarily affect mental health outcomes. The focus of
our analysis was not on environmental and occupational risks (e.g.,
exposure to urban particle pollution, radon, and arsenic),
primarily because for many of these risks nationally representative
data on population exposure using the same metrics as used in
epidemiological studies are unavailable. Comparative analyses of
these risks should be a priority for future research.
Data Sources
We obtained risk factor exposure distributions from nationally
representative health examination and interview surveys, etiological
effect sizes from published or new systematic reviews and meta-
analyses of epidemiological studies, and the number of deaths by
cause from the National Center for Health Statistics (NCHS).
Riskfactorexposure. Formost risk factorsinthis analysis, we
used data from the National Health and Nutrition Examination
Survey (NHANES) to measure population exposures (Table 1).
NHANES uses a complex multi-stage, stratified, clustered
probability sample design to provide nationally representative
data on health and nutrition characteristics of the civilian,
noninstitutionalized US population. NHANES includes an in-
person interview and a subsequent examination component in a
MEC(mobile examination clinic); thoseunable tovisittheMECare
offered a limited examination at home. We used two NHANES
rounds that covered 2003–2006 to provide sufficient sample size for
exposure estimates by age and sex, for years as close as possible to
the latest year for which mortality data were available (2005). The
total sample size for the 2003–2006 rounds was 20,470. Additional
information on survey design and methods is available at http://
www.cdc.gov/nchs/nhanes.htm. We adjusted the intakes of fruits
and vegetables, omega-3 fatty acids, and salt (sodium) from
NHANES for total energy intake using the residual method [4].
We used the National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC) to measure the quantity of alcohol
consumed and the pattern of consumption. NESARC is a multi-
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of the noninstitutionalized US population, whose target population
includes boarding houses, rooming houses, nontransient hotels and
motels, shelters, facilities for housing workers, college quarters, and
group homes. The 2001–2002 sample size was 43,093. Detailed
information on frequency, amount, and type of beverage during
the previous 12 mo was sought using computer assisted personal
interviewing. Average daily alcohol consumption in NESARC was
estimated using responses to questions on both the usual quantity-
and-frequency of drinking, and quantity-and-frequency of binge
drinking. This method provides a more valid estimate of average
consumption than do calculations based solely on questions
regarding usual drinking [5]. A summary is available online at
http://www.census.gov/rophi/www/nesarc.html.
We accounted for complex survey design and sampling weights
in estimating exposures. Using one-off measurements in health
examination surveys overestimates the standard deviation (SD) of
the ‘‘usual’’ population exposure distribution, due to within-person
variation. We estimated the usual population SD of blood
pressure, fasting plasma glucose (FPG), and LDL cholesterol by
multiplying the SD of NHANES sample by the dilution ratio from
studies that had multiple exposure measurements [6–8]. We did
not adjust the SD of BMI for within-person variations in body
weight, because studies with multiple BMI measurements have not
found evidence for substantial within-person variability in BMI
[9]. For dietary factors, we calculated the SD of population
exposure by partitioning the within- and between-person variabil-
ities of the two 24-h diet recalls using a random-effect regression
model (using XTREG in STATA software). We also did not adjust
the distributions of alcohol use and physical activity, because there
were very few prospective studies with multiple measurements to
provide reliable evidence for the relationship between one-off and
usual exposure distributions [9,10].
Etiological effects of risk factors on disease-specific
mortality. We obtained the relative risk (RR) per unit of
exposure (for risks measured continuously) or for each exposure
category (for risks measured in categories) for diseases with
probable or convincing causal associations with each risk factor,
based on the most recent published systematic reviews and meta-
analyses of epidemiological studies or by conducting new
systematic reviews and meta-analyses when they were not
available in the published literature (Tables 2–7).
The studies used for etiological effect sizes included both
randomized intervention studies of exposure reduction and
observational studies (primarily prospective cohort studies) that
estimated the effects of baseline exposure. The majority of
observational studies used for effect sizes had adjusted for
important potential confounding factors. Each RR used in our
analysis represents the best evidence for the proportional effect of
risk factor exposure on disease-specific mortality in the population
based on the current causes and determinants of the population
distribution of exposure (see also Discussion).
We used RRs for blood pressure, LDL cholesterol, and FPG
that were adjusted for regression dilution bias using studies that
had repeated exposure measurement [7,11,12]; for blood pressure
and LDL cholesterol, the adjusted magnitude is supported by
effect sizes from randomized studies [13,14]. Evidence from a
large prospective study with multiple measurements of weight and
height showed that regression dilution bias did not affect the RRs
for BMI, possibly because there is less variability [15]. RRs for
dietary salt and PUFA-SFA replacement were from intervention
studies, and hence unlikely to be affected by regression dilution
bias. RRs for dietary trans fatty acids were primarily from studies
that had used cumulative averaging of repeated measurements
[16] that reduces but may not fully correct for regression dilution
bias. RRs for physical inactivity, alcohol use, smoking, and dietary
omega-3 fatty acids and fruits and vegetables were not corrected
for regression dilution bias due to insufficient current information
from epidemiological studies on exposure measurement error and
variability, which is especially important when error and
variability of self-reported exposure may themselves differ across
studies.
For each risk factor–disease pair, we used the same RR for men
and women except where empirical evidence indicated that the
RR differed by sex: colon and pancreas cancers caused by high
BMI [17], and all disease outcomes caused by alcohol use and
tobacco smoking, for which there are sex differences in factors
such as smoking duration and intensity [18] and type of alcohol
consumed [19]. The RRs for some risk factor–disease associations
vary by age, especially for cardiovascular diseases. We used
consistent age-varying distributions of RRs across risk factors and
diseases (Tables 2–7).
The current evidence suggests that when measured comparably
the proportional effects of the risk factors considered in this
analysis are similar across populations, e.g., Western and Asian
populations [7,20,21]. The exception to this observation is the
effects of alcohol use on ischemic heart disease (IHD) where the
pattern of drinking (regular versus binge) determines the RR. We
used both the average quantity of alcohol consumed as well as the
drinking pattern in our analysis of exposure and RRs for alcohol
use and IHD. The effects of alcohol on injuries and violence may
also be modified by social, policy, and transportation factors.
Therefore, we did not pool epidemiological studies on the injury
effects of alcohol from different countries, but used data sources
that appropriately measure effects in the US (Table 4).
Disease-specific deaths. The number of disease-specific
deaths, by age and sex, was obtained from the NCHS, which
maintains records for all deaths in the US. Although the US has
automated (computerized) assignment of an International
Classification of Diseases (ICD) code for the underlying cause of
death, the validity and comparability of cause of death statistics
may be affected at the time of medical certification, especially for
cardiovascular causes and diabetes [22–24]. We adjusted for
incomparability in cause of death assignment using previously
described methods [22,23]. This adjustment required information
on multiple contributing causes of death and county of residence.
We obtained county identifiers for all deaths in 2005 through a
special request to the NCHS.
Several risk factors have different effects on ischemic and
hemorrhagic stroke (Table 1). Slightly more than 50% of stroke
deaths in 2005 were assigned to unspecified subtype (ICD-10 code
I-64). We redistributed these deaths to ischemic and hemorrhagic
stroke using proportions from large epidemiological studies with
high-quality diagnosis and cause-of-death assignment [25],
stratified by age using a meta-analysis of stroke registries in
Western populations [26].
Estimating Mortality Attributable to Risk Factors
For each risk factor and for each disease causally associated
with its exposure, we computed the proportional reduction in
disease-specific deaths that would occur if risk factor exposure had
been reduced to an alternative level. This is known as the
population-attributable fraction (PAF) and measures the total
effects of a risk factor (direct as well as mediated through other
factors). For risks measured continuously (blood pressure, BMI,
LDL cholesterol, FPG, dietary fruits and vegetables, and trans and
polyunsaturated fatty acids), we computed PAFs using the
Mortality Effects of Risk Factors in the US
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PAF~
Ð m
x~0
RR x ðÞ Px ðÞ dx{
Ð m
x~0
RR x ðÞ P’ x ðÞ dx
Ð m
x~0
RR x ðÞ Px ðÞ dx
ð1Þ
Where x=exposure level; P(x)=actual distribution of exposure in
the population; P9(x)=alternative distribution of exposure in the
population; RR(x)=relative risk of mortality at exposure level x;
and m=maximum exposure level.
For risks measured in categories of exposure (smoking, physical
inactivity, alcohol use, and dietary omega-3 fatty acids), we used
the discrete version of the same estimator for PAF.
Table 2. Sources and magnitudes of relative risks for the effects of continuous dietary risk factors on disease-specific mortality.
Risk Factor Disease Outcome Source of RR Units Age Group RR
High dietary trans
fatty acids
IHD
a Meta-analysis of three prospective
cohort studies [16]
Per one percentage point more
calories
30–44 1.40
45–59 1.29
60–69 1.14
70–79 1.08
80+ 1.06
Low dietary PUFA (in
replacement of SFA)
IHD
a Meta-analysis of seven intervention
studies by authors
b
Per one percentage point less
calories from PUFA, in isocaloric
exchange for SFA
b
30–44 1.05
45–59 1.04
60–69 1.02
70–79 1.01
80+ 1.01
High dietary salt SBP Meta-analysis of dietary trials mmHg SBP per 100 mmol/d
dietary sodium
SBP$140 mmHg 7.11
SBP,140 mmHg 3.57
Stomach cancer Meta-analysis of three prospective
cohort studies [74]
Per 100 mmol/d dietary sodium — 1.57
Low intake of fruits
and vegetables
IHD Meta-analysis of six prospective
cohort studies [75]
Per 80 g/d lower intake 30–69 1.04
70–79 1.03
80+ 1.02
Ischemic stroke Meta-analysis of three prospective
cohort studies [76]
Per 80 g/d lower intake 30–69 1.06
70–79 1.05
80+ 1.03
Lung cancer Meta-analysis of major observational
studies [67]
Per 80 g/d lower intake 30–69 1.04
70–79 1.03
80+ 1.02
Stomach cancer Meta-analysis of major observational
studies [67]
Per 80 g/d lower intake 30–69 1.06
70–79 1.05
80+ 1.03
Colorectal cancer Meta-analysis of major observational
studies [67]
Per 80 g/d lower intake 30–69 1.01
70–79 1.01
80+ 1.00
Esophagus, mouth,
and pharynx cancers
Meta-analysis of major observational
studies [77]
Per 80 g/d lower intake 30–69 1.10
70–79 1.08
80+ 1.05
aFor these risk factor–disease pairs, RRs in the source were reported for all ages combined. We used median age at event and the age pattern of excess risk for serum
total cholesterol and IHD to estimate RRs for each age category.
bThe interventions studies replaced dietary SFA with PUFA, hence the RRs measure the effect of replacement. Effects of replacing PUFA for other macronutrients have
not been evaluated in randomized interventions studies. However, evidence from cohort studies suggests that replacement of PUFA for carbohydrates, but not
carbohydrates for SFA, would produce similar benefits [78], indicating that the measured benefits are due to PUFA.
doi:10.1371/journal.pmed.1000058.t002
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alcohol use on injuries. A number of emergency room studies have
collected information on alcohol consumption in the 6 h prior to
the injury among injury patients. Injuries that occur among
patients who had consumed alcohol prior to their injury were
classified as ‘‘alcohol-related’’ injuries. Because some of these
injuries would have occurred in the absence of alcohol, not all are
caused by alcohol use; in other words, the proportion of alcohol-
attributable injuries is lower than that of alcohol-related injuries.
Highway studies have quantified the increased risk of road traffic
deaths among drivers who have consumed alcohol according to
the drivers’ blood alcohol concentration, often reported as odds
ratios (ORs). Ideally, ORs would be used in conjunction with data
on population prevalence of intoxication to calculate PAF.
Because intoxication data were not available, we used a slightly
modified equation to calculate the PAF using ORs from highway
studies and data on alcohol-related injuries:
PAF% proportion alcohol   related ðÞ |
OR{1
OR
  
ð2Þ
The proportion of alcohol-related injuries was obtained from
Fatality Analysis Reporting System (FARS) for road traffic injuries
and from a meta-analysis of emergency room studies for other
types of intentional and unintentional injuries [27,28]. FARS is a
census of fatal crashes maintained by the National Highway
Traffic Safety Administration and includes information on the
blood alcohol concentration (BAC) level of drivers involved in fatal
crashes, regardless of whether the decedent was the driver or not.
Beginning in 2001, National Center for Statistics and Analysis uses
a multiple imputation method to impute ten values for each
missing BAC value. Additional information on FARS is available
at http://www-fars.nhtsa.dot.gov/Main/index.aspx. The sources
for ORs are provided in Table 4.
We calculated the number of deaths from each causally related
disease outcome attributable to a risk factor by multiplying its PAF
by total deaths from that disease. Disease-specific deaths
attributable to each risk factor were summed to obtain the total
(all-cause) attributable deaths. Deaths from different diseases
attributable to a single risk factor are additive because in mortality
statistics based on the ICD, each death is categorically assigned to
a single underlying cause (disease) with no overlap between
disease-specific deaths. However, the deaths attributable to
individual risk factors often overlap and should not be summed
(see Discussion).
To measure the mortality effects of all non-optimal levels of
exposure consistently and comparably across risk factors, we used
an optimal exposure distribution, referred to as the theoretical-
minimum-risk exposure distribution (TMRED), as the alternative
exposure distribution (Table 1). The TMREDs were zero for risk
factors for which zero exposure led to minimum risk (e.g., no
tobacco smoking). For BMI, blood pressure, blood glucose, and
LDL cholesterol, zero exposure is physiologically impossible. For
these risks we used TMREDs based on the levels corresponding to
the lowest mortality rate in epidemiological studies or the levels
observed in low-exposure populations (Table 1). Alcohol use may
be beneficial or harmful depending on the specific disease outcome
and patterns of alcohol consumption [29,30]. We used a TMRED
of zero for alcohol in our primary analysis, and regular drinking of
small amounts as the TMRED in a sensitivity analysis. The
TMREDs for factors with protective effects (physical activity and
dietary PUFA-SFA replacement, omega-3 fatty acids, and fruits
and vegetables) were selected as the intake and activity levels to
which beneficial effects may plausibly continue based on the
evidence from current studies. For example, intake of omega-3
fatty acids seems to reduce IHD mortality at intakes up to
250 mg/d, but has relatively little additional mortality benefits at
higher intakes [31]. In setting TMREDs for protective factors, we
also took into account the levels observed in populations that have
high intake, e.g., for fruits and vegetables.
Table 3. Sources and magnitudes of relative risks (RRs) for the effects of categorical dietary risk factors on disease-specific
mortality.
Risk Factor
Disease
Outcome Source of RR Age Group RR 1 RR 2 RR 3 RR 4 RR 5
Low dietary omega-3
fatty acids
a
IHD
b Meta-analysis of randomized
intervention studies and prospective
cohort studies [31]
c
30–44 2.18 1.80 1.46 1.14 1.00
45–59 1.86 1.58 1.33 1.10 1.00
60–69 1.41 1.28 1.16 1.05 1.00
70–79 1.23 1.16 1.09 1.03 1.00
80+ 1.19 1.13 1.07 1.02 1.00
Stroke
b Meta-analysis of 12 prospective cohort
studies by authors
c
30–44 1.27 1.19 1.11 1.04 1.00
45–59 1.27 1.19 1.11 1.04 1.00
60–69 1.16 1.11 1.06 1.02 1.00
70–79 1.11 1.08 1.04 1.01 1.00
80+ 1.10 1.07 1.04 1.01 1.00
aOmega-3 intake categories in the analysis were (1) 0 to ,62.5; (2) 62.5 to ,125; (3) 125 to ,187.5; (4) 187.5 to ,250; and (5) $250 mg/d of eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA).
bFor each disease outcome, RRs in the source were reported for all ages combined. We used median age at event and the age pattern of excess risk for serum total
cholesterol and the same disease to estimate RRs for each age category.
cRRs were summarized via meta-regression across intake levels [79]. When RRs were reported for fish intake, we converted the units to omega 3 intake using the
average omega-3 content of one serving of fish estimated using NHANES 2003–2004.
doi:10.1371/journal.pmed.1000058.t003
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Disease Outcome Source of RR Age Group Sex Abstainers DI
a DII
a DIII
a Binge Drinkers
IHD
a Meta-analysis of observational
studies for non-binge [19,30]
and binge drinkers [80]
30–44 — 1.00 0.60 0.62 1.00 1.00
45–59 — 1.00 0.63 0.65 1.00 1.00
60–69 — 1.00 0.82 0.83 1.00 1.00
70–79 — 1.00 0.92 0.93 1.00 1.00
80+ — 1.00 0.97 0.98 1.00 1.00
Ischemic stroke
b Meta-analysis of 35
observational studies [19,81]
30–44 M 1.00 0.83 0.83 3.84 —
F 1.00 0.88 1.07 1.33 —
45–59 M 1.00 0.88 0.88 2.52 —
F 1.00 0.91 1.05 1.22 —
60–69 M 1.00 0.94 0.94 1.69 —
F 1.00 0.96 1.02 1.10 —
70–79 M 1.00 0.97 0.97 1.32 —
F 1.00 0.98 1.01 1.05 —
80+ M 1.00 1.00 1.00 1.00 —
F 1.00 1.00 1.00 1.00 —
Hemorrhagic stroke
b Meta-analysis of 35
observational studies [19,81]
30–44 M 1.00 1.65 3.16 6.65 —
F 1.00 1.30 2.07 3.89 —
45–59 M 1.00 1.42 2.21 3.60 —
F 1.00 1.20 1.67 2.54 —
60–69 M 1.00 1.19 1.55 2.18 —
F 1.00 1.09 1.30 1.70 —
70–79 M 1.00 1.09 1.25 1.55 —
F 1.00 1.04 1.13 1.32 —
80+ M 1.00 1.00 1.00 1.00 —
F 1.00 1.00 1.00 1.00 —
Hypertensive disease Overview of observational
studies [19,82,83]
— M 1.00 1.4 2.0 4.1 —
— F 1.00 1.4 2.0 2.0 —
Cardiac arrhythmias Overview of observational
studies [82]
— — 1.00 1.51 2.23 2.23 —
Breast cancer Systematic review of
epidemiological
studies [19,82,83]
30–44 F 1.00 1.15 1.41 1.46 —
45+ F 1.00 1.14 1.38 1.62 —
Colorectal cancer Pooled analysis of 8
prospective cohort
studies [84]
— M 1.00 1.0 1.16 1.41 —
— F 1.00 1.0 1.01 1.41 —
Esophagus cancer Overview of observational
studies [19,82,83]
— — 1.00 1.80 2.38 4.36 —
Mouth and pharynx
cancer
Overview of observational
studies [19,82,83]
— — 1.00 1.45 1.85 5.39 —
Laryngeal cancer Overview of observational
studies [82]
— — 1.00 1.83 3.90 4.93 —
Liver cancer Overview of observational
studies [19,82,83]
— — 1.00 1.45 3.03 3.60 —
Selected other cancers
c Overview of observational
studies [19,83]
— — 1.00 1.1 1.3 1.7 —
Diabetes mellitus Overview of observational
studies [19,82,83]
— M 1.00 0.99 0.57 0.73 —
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44, 45–59, 60–69, 70–79, and $80 y). We restricted analyses to
$30 y because there are limited data on the mortality effects of
these risk factors at younger ages and because there are few deaths
from diseases affected by these risks in younger ages (about 10,000
deaths from the relevant non-injury causes in Americans ,30 y
versus 1,745,000 in those $30 y). The exception was the effect of
alcohol use on injuries for which we also included 0- to 29-y-olds
because there are substantial injury deaths at these ages. Therefore,
we can assess both the role of alcohol use as a cause of injuries in
young drinkers and the effect of alcohol use by any drinker (e.g., an
intoxicated driver) on injury in young nondrinkers.
Uncertainty and Sensitivity Analyses
We estimated the uncertainty of the number of deaths
attributable to each risk factor as caused by sampling variability.
To compute sampling uncertainty, we used a simulation approach
to combine the uncertainties of exposure distributions and RRs in
each age–sex group. In the simulation method, we drew
repeatedly from the distributions of exposure mean and SD (for
continuous risks) or prevalence in each exposure category (for
categorical risks). The uncertainty of these parameters was
characterized using normal, Chi-square, or binomial distributions.
RRs for each disease were drawn from a log-normal distribution
independently from exposure. Each set of exposure and disease-
specific RR draws was used to calculate the PAFs for all diseases
associated with the risk factor, separately by age and sex. We used
500 draws for each risk factor, and report 95% confidence
intervals (CIs) based on the resulting distributions of 500 estimated
attributable deaths. Further simulation details and computer code
are available from the authors by request.
In addition to sampling uncertainty, we examined the sensitivity
of our results to important methodological factors and data
sources. The methodological factors and data sources in the
sensitivity analyses included the choice of exposure metrics, the
shape of the exposure distribution, the TMREDs, disease
outcomes causally associated with risk factors, and etiological
effect sizes (Table S1).
We used RRs adjusted for major potential confounders to
estimate the causal components of risk factor–disease associations.
However, if there is also a correlation between exposure and
disease-specific mortality, due to correlations of exposure with
other risks or other unobserved factors, the above equations may
result in under- (when there is positive correlation) or over-
estimation (negative correlation) of the true PAF when used with
adjusted RRs [32–36]. To assess the effect of correlation, we also
calculated PAFs that incorporated correlations between risk factors
or between risk factors and underlying disease-specific mortality in
multiple sensitivity analyses. Ideally the analyses of risk factor
correlations would have used the complete multivariate distribu-
tion of exposure to all risk factors and disease outcomes. However,
the sources in this analysis did not provide data on the joint
exposure distributions of all risk factors together. Therefore, our
analyses of risk factor correlation using current data sources were
limited to risk factor pairs.
Analyses were conducted using Stata version 10 (Stata Corp,
College Station, Texas) and SAS version 9.1 (SAS Institute, Cary,
NC).
Results
In the year 2005, 2,448,017 US residents died; 49% of these
deaths were among men. Ninety-six percent of all deaths in the US
were in people $30 y of age. After adjustment for comparability of
cause-of-death assignment [22,23], the four most common causes
of death were IHD (434,000 deaths), lung cancer (163,000 deaths),
stroke (150,000 deaths), and chronic obstructive pulmonary
diseases (124,000 deaths).
Total Mortality Effect of Risk Factors
Tobacco smoking was responsible for an estimated 467,000
(95% CI 436,000–500,000) deaths and high blood pressure for
Disease Outcome Source of RR Age Group Sex Abstainers DI
a DII
a DIII
a Binge Drinkers
— F 1.00 0.92 0.85 1.13 —
Liver cirrhosis Overview of observational studies
[19,82,83]
— — 1.00 1.3 9.5 13 —
Acute and chronic
pancreatitis
Meta-analysis of observational
studies [85]
— M 1.00 1.3 1.8 3.2 —
— F 1.00 1.3 1.8 1.8 —
BAC % ,0.01 0.01–0.04 0.05–0.07 0.08–0.1 $0.11
Road traffic injury
deaths
Grand Rapids Study [19,86]
d OR 1.0 1.2 1.7 4.0 10.7
Falls, homicide and
suicide, and other
injury deaths
Grand Rapids Study [19,86]
d OR 10.7
e ————
aExposure categories were: Abstainer, a person not having had a drink containing alcohol within the last year; DI 0–19.99 g of pure alcohol daily (females) and 0–39.99 g
(males); DII, 20–39.99 g (females) and 40–59.99 g (males); and DIII, .40 g (females) and .60 g (males). Binge drinking was defined as having at least one occasion of
five or more drinks in the last month. For IHD, the categories refer to non-binge drinkers.
bFor these risk factor–disease pairs, RRs in the source were reported for all ages combined. We used median age at event and the age pattern of excess risk from
smoking and the same disease to estimate RRs for each age category.
cThis category includes ICD-9 codes 210–239.
dThese odds ratios were used to estimate PAF as described in the Methods section.
eUsed to estimated PAF for having drunk alcohol in the last 6 h before injury.
doi:10.1371/journal.pmed.1000058.t004
Table 4. cont.
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in five or six deaths in US adults in 2005 (Figure 1A, Table 8).
Overweight–obesity, physical inactivity, and high blood glucose
each caused 190,000–216,000 deaths (8%–9% of all deaths in
adults). The mortality effects of individual dietary risk factors
ranged from 15,000 deaths for low dietary PUFA (,1% of all
deaths) to 82,000–102,000 deaths for low dietary omega-3 fatty
acids, high dietary trans fatty acids, and high dietary salt. Alcohol
use caused 90,000 deaths from road traffic and other injuries,
violence, chronic liver disease, cancers, alcohol use disorders,
hemorrhagic stroke, arrhythmias and hypertensive disease, but
also averted a balance of 26,000 deaths from IHD, ischemic
stroke, and diabetes, due to benefits among those who drank
alcohol moderately and regularly.
Mortality Effects of Risk Factors by Disease
Most deaths attributable to these risks were from cardiovascular
diseases (Figure 1). Cancers, respiratory diseases, diabetes, and
injuries nonetheless accounted for at least 23% of all deaths caused
by smoking, alcohol use, high blood glucose, physical inactivity,
low intake of fruits and vegetables, and overweight–obesity. The
single largest risk factor for cardiovascular mortality in the US was
high blood pressure, responsible for an estimated 395,000 (95% CI
372,000–414,000) cardiovascular deaths (45% of all cardiovascu-
lar deaths), followed by overweight–obesity, physical inactivity,
high LDL cholesterol, smoking, high dietary salt, high dietary
trans fatty acids, and low dietary omega-3 fatty acids. Smoking
had the largest effect on cancer mortality compared with any other
risk factor, causing an estimated 190,000 (184,000–194,000) or
33% of all cancer deaths.
Mortality Effects of Risk Factors by Sex and Age
High blood pressure was the leading cause of death in women
(231,000 deaths [95% CI 213,000–249,000], 19% of all female
deaths), whereas smoking remains the leading cause of death in
men (248,000 deaths [226,000–269,000], 21% of all male deaths).
The leading causes of death in men and women were different
because women have higher blood pressure and men higher
cumulative (i.e., current and former) smoking. Overweight–
obesity, physical inactivity, and high blood glucose were the third
to fifth causes of death for both sexes (Figure 1B and 1C). High
dietary salt was responsible for slightly more deaths than high LDL
cholesterol in women.
The mortality effects of all individual risk factors except alcohol
use were almost equally divided between men and women (i.e., at
least 40% of deaths attributable to each individual risk factor were
either in men or in women). Seventy percent of all deaths
attributable to alcohol use occurred in men (45,000 deaths),
because men consumed more alcohol and had more binge
drinking.
Table 5. Sources and magnitudes of relative risks for the effects of physical inactivity on disease-specific mortality.
Disease Outcome Source of RR Age Group Highly Active
Recommended
Level Active
Insufficiently
Active Inactive
IHD Meta-analysis of 20 prospective
cohort studies [87]
a
30–69 1.00 1.15 1.66 1.97
70–79 1.00 1.15 1.51 1.73
80+ 1.00 1.15 1.38 1.50
Ischemic stroke Meta-analysis of 8 prospective
cohort studies [87]
a
30–69 1.00 1.12 1.23 1.72
70–79 1.00 1.12 1.21 1.55
80+ 1.00 1.12 1.18 1.39
Breast cancer Meta-analysis of 12 prospective
cohort and 31 case-control
studies [87]
a
30–44 1.00 1.25 1.41 1.56
45–69 1.00 1.25 1.41 1.67
70–79 1.00 1.25 1.36 1.56
80+ 1.00 1.25 1.32 1.45
Colon cancer Meta-analysis of 11 prospective
cohort and 19 case-control
studies [87]
a
30–69 1.00 1.07 1.27 1.80
70–79 1.00 1.07 1.21 1.59
80+ 1.00 1.07 1.16 1.39
Diabetes Meta-analysis of 13 prospective
cohort and 9 case-control
studies [87]
a
30–69 1.00 1.21 1.50 1.76
70–79 1.00 1.21 1.43 1.60
80+ 1.00 1.21 1.34 1.45
Categories of physical activity were defined as below using responses to questions regarding physical activity during the past 30 d: inactive, no moderate or vigorous
physical activity; low-active, ,2.5 h/wk of moderate activity or ,600 met?min/wk; moderately active: either $2.5 h/wk of moderate activity or $1 h of vigorous activity
and $600 met?min/wk; highly active: $1 h/wk of vigorous activity and $1,600 met?min/wk.
aThe meta-analysis of RRs for physical inactivity used three categories: inactive, insufficiently active, and recommended-level active. For this analysis, we re-scaled the
RRs to set the highly active group as the reference category. The ratio of excess risk from recommended-level active to high-active was from Manson et al. for IHD [69],
Hu et al. for ischemic stroke [70], Patel et al. 2003 for breast cancer [71], and Chao et al. for colon cancer [72].
doi:10.1371/journal.pmed.1000058.t005
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30 and 45 y of age. No individual risk factor was responsible for
more than 7% of deaths in this age group. However, this age
group bore 34% of alcohol-caused injuries (Table 9), making
Table 6. Sources and magnitudes of relative risks for the
effects of tobacco smoking on disease-specific mortality.
Disease
Outcome Source of RR
Age
Group Sex RR
IHD American Cancer Society
Cancer Preventions Study,
Phase II (ACS CPS-II) [88]
a
30–44 M 5.51
F 2.26
45–59 M 3.04
F 3.78
60–69 M 1.88
F 2.53
70–79 M 1.44
F 1.68
80+ M 1.05
F 1.38
Stroke ACS CPS-II [88]
a 30–44 M 3.12
F 4.61
45–59 M 3.12
F 4.61
60–69 M 1.88
F 2.81
70–79 M 1.39
F 1.95
80+ M 1.05
F 1.00
Hypertensive
disease
(sensitivity
analysis)
b
ACS CPS-II [88]
a 30–44 M 5.93
F 2.38
45–59 M 3.23
F 4.05
60–69 M 1.96
F 2.67
70–79 M 1.48
F 1.74
80+ M 1.06
F 1.42
Selected other
cardiovascular
diseases
b
ACS CPS-II [88]
a 30–44 M 6.91
F 2.65
45–59 M 3.68
F 4.65
60–69 M 2.15
F 3.00
70–79 M 1.58
F 1.89
80+ M 1.07
F 1.50
Diabetes
mellitus
Meta-analysis of 25
prospective cohort
studies with 1.2 million
participants [89]
a
— — 1.44
Disease
Outcome Source of RR
Age
Group Sex RR
Lung cancer ACS CPS-II [90]
a — M 21.3
F 12.5
Mouth,
pharynx, and
esophagus
cancer
ACS CPS-II [90]
a —M 8 . 1
F6 . 0
Stomach
cancer
ACS CPS-II [90]
a — M 2.16
F 1.49
Liver cancer ACS CPS-II [90]
a — M 2.33
F 1.50
Pancreas
cancer
ACS CPS-II [90]
a — — 2.20
Cervix uteri
cancer
ACS CPS-II [90]
a — F 1.50
Bladder
cancer
ACS CPS-II [90]
a — M 3.00
F 2.40
Leukemia ACS CPS-II [90]
a — M 1.89
F 1.23
Colorectal
cancer
(sensitivity
analysis)
ACS CPS-II [90,91]
a — M 1.32
F 1.41
Kidney and
other urinary
cancer
ACS CPS-II [90]
a —M 2 . 5
F1 . 5
Chronic
obstructive
pulmonary
disease
ACS CPS-II [92]
a — M 10.8
F 12.3
Other
respiratory
diseases
c
ACS CPS-II [92]
a — M 1.90
F 2.20
Tuberculosis Meta-analysis of cohort,
case-control, and
cross-sectional
studies [93]
— — 1.62
aWe used ACS CPS-II as the source of RRs because the Smoking Impact Ratio
(SIR), which was used as the exposure metric for tobacco smoking in the main
analysis, is calculated using ACS CPS-II cohort and because the study provided
separate RRs for different cancers and cardiovascular diseases by age. The CPS-
II RRs were also adjusted for multiple potential confounders.
bFor these disease outcomes, RRs in the source were reported for all ages
combined. We used median age at event and the age pattern of excess risk
from IHD to estimate RRs for each age category.
cThis category includes lower respiratory tract infections and asthma.
doi:10.1371/journal.pmed.1000058.t006
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Risk Factor Disease Outcome Source of RR Units Age Group Sex RR
High blood
glucose
IHD Meta-analysis of 19 prospective cohort
studies with 237,000 participants [7]
a
Per mmol/l increase 30–59 — 1.42
60–69 — 1.20
70+ — 1.20
Stroke Meta-analysis of 19 prospective cohort
studies with 237,000 participants [7]
a
Per mmol/l increase 30–59 — 1.36
60–69 — 1.28
70+ — 1.08
Renal failure Randomized trial of 3,900 participants [94] Per mmol/l increase — 1.26
High LDL
cholesterol
IHD Meta-analysis of ten prospective cohort
studies [12]
Per mmol/l increase 30–44 — 2.94
45–59 — 2.10
60–69 — 1.59
70–79 — 1.27
80+ — 1.01
Ischemic stroke
b Meta-analysis of nine prospective cohort
studies [12]
Per mmol/l increase 30–44 — 1.30
45–59 — 1.30
60–69 — 1.18
70–79 — 1.00
c
80+ — 1.00
c
High total
cholesterol
(sensitivity
analysis)
IHD PSC meta-analysis of 61 prospective
cohort studies with 900,000 European
and North American participants [95]
Per mmol/l increase 30–44 — 2.11
45–59 — 1.81
60–69 — 1.39
70–79 — 1.22
80+ — 1.18
Ischemic stroke PSC [95] Per mmol/l increase 30–44 — 1.51
45–59 — 1.37
60–69 — 1.12
70–79 — 1.00
c
80+ — 1.00
c
High blood
pressure
IHD PSC [11] Per 20 mmHg increase 30–44 — 2.04
45–59 — 2.01
60–69 — 1.85
70–79 — 1.67
80+ — 1.49
Stroke PSC [11] Per 20 mmHg increase 30–44 — 2.55
45–59 — 2.74
60–69 — 2.33
70–79 — 2.00
80+ — 1.49
Hypertensive disease
b PSC [11] Per 20 mmHg increase 30–44 — 4.78
45–59 — 5.02
60–69 — 4.55
70–79 — 4.10
80+ — 3.50
Other cardiovascular
diseases
d
PSC [11] Per 20 mmHg increase 30–44 — 2.52
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45–59 — 2.11
60–69 — 1.89
70–79 — 1.56
80+ — 1.43
Overweight–
obesity
(high BMI)
IHD APCSC meta-analysis of 33 prospective
cohorts with 310,000 participants [65]
e,f
Per kg/m
2 increase 30–44 — 1.14
45–59 — 1.09
60–69 — 1.08
70–79 — 1.05
80+ — 1.02
Ischemic stroke APCSC [65] Per kg/m
2 increase 30–44 — 1.14
45–59 — 1.10
60–69 — 1.08
70–79 — 1.05
80+ — 1.03
Hypertensive disease APCSC [65] Per kg/m
2 increase 30–44 — 1.22
45–59 — 1.18
60–69 — 1.14
70–79 — 1.11
80+ — 1.08
Postmenopausal breast
cancer
Meta-analysis of 31 prospective cohort
studies [17]
Per kg/m
2 increase 45+ F 1.02
Colon cancer Meta-analysis of 22 prospective cohort
studies in males and 19 in females [17]
Per kg/m
2 increase — M 1.04
F 1.02
Corpus uteri cancer Meta-analysis of 19 prospective cohort
studies [17]
Per kg/m
2 increase — F 1.10
Kidney cancer Meta-analysis of 11 prospective cohort
studies in males and 12 in females [17]
Per kg/m
2 increase — 1.05
Pancreatic cancer Meta-analysis of 12 prospective cohort
studies in males and 11 in females [17]
Per kg/m
2 increase — M 1.01
F 1.02
Non-Hodgkin lymphoma
(sensitivity analysis)
Meta-analysis of six prospective cohort
studies in males and seven in females [17]
Per kg/m
2 increase — — 1.01
Diabetes mellitus APCSC meta-analysis prospective cohort
studies with 150,000 participants [96]
Per kg/m
2 increase 30–59 — 1.20
60–69 — 1.16
70+ — 1.11
aSee Danaei et al. [61] for sensitivity to using RRs from systematic reviews of other epidemiological studies.
bFor these risk factor–disease pairs, RRs in the source were reported for all ages combined. We used median age at event and the age pattern of excess risk from
another risk factor and the same disease (e.g., age pattern of total serum cholesterol and ischemic stroke was applied to LDL and ischemic stroke) or from the same risk
factor and another disease (e.g., age pattern of excess risk for SBP and all cardiovascular diseases was applied to SBP and hypertensive disease) to estimate RRs for each
age category.
cWe used a null association in those 70-y-old and older because RRs in two large meta-analyses of prospective studies [95,97] were not statistically significant from null,
and did not show consistent benefits for lower total cholesterol in these ages. There is some evidence from clinical trials that statins reduce the risk of stroke in older
ages [98]. However, statins may reduce stroke mortality through other, non-cholesterol mechanisms such as stabilization of atherosclerotic plaques [99]. In the
sensitivity analysis for high LDL cholesterol and ischemic stroke, we used an RR of 1.12 in these age groups.
dThis category includes rheumatic heart disease, acute and subacute endocarditis, cardiomyopathy, other inflammatory cardiac diseases, valvular disorders, aortic
aneurysm, pulmonary embolism, conduction disorders, peripheral vascular disorders, and other ill-defined cardiovascular diseases.
eWe used meta-analyses of studies with measured weight and height because using self-reported weight and height can lead to bias in estimated RRs. The correlation
between self-reported and measured weight, as found in selected studies [100,101], does not remove the possibility of bias because even with perfect correlation, the
absolute bias in self-reported weight and height may be a function of its true value.
fThe RRs reported for Asian and Australia–New Zealand populations were not significantly different in this meta-analysis providing empirical evidence on absence of
significant effect modification in the multiplicative scale by ethnicity. A meta-analysis of studies in Europe and North America included studies [102] with self-reported
height and weight and was thus not used in this analysis. The RRs reported in that meta-analysis ranged from 1.02 to 1.26 and the average RR weighted by number of
cases was 1.07 per kg/m
2 which is almost equal to the RR for 60- to 69-y-olds in this analysis.
APCSC, Asia-Pacific Cohorts Studies Collaboration; PSC, Prospective Studies Collaboration.
doi:10.1371/journal.pmed.1000058.t007
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alcohol use. Eighty percent of deaths attributable to high blood
pressure and 68% and 70% of those attributable to high dietary
salt and physical inactivity, respectively, occurred after 70 y of age
(Table 9). Conversely, 40% or more of all deaths attributable to
high LDL cholesterol, overweight–obesity, high dietary trans fatty
acids, low dietary PUFA and omega-3 fatty acids, low intake of
fruits and vegetables, alcohol use, and smoking occurred before
70 y of age (Table 9). As a result, when the young and middle-aged
(#70 y of age) mortality effects of these risk factors were evaluated,
smoking was by far the leading cause of death in both men and
women #70 y, followed by overweight–obesity (Figure 2).
Mortality Effects of Risk Factor by Exposure Level
There was substantial variation in how deaths attributable to
these risks were distributed below or above commonly used
thresholds and guidelines (Table 10): close to two-thirds of deaths
attributable to high blood pressure (66%), high BMI (63%), and
high blood glucose (60%) occurred in people who would be
clinically classified as hypertensive, obese, or diabetic, even though
these groups make up only 10%–33% of the US adult population
(note that the estimated benefits in these people would be achieved
if risk factor levels are reduced to their TMREDs, and not simply
to the clinical threshold). In contrast, more than one-half of deaths
attributable to high LDL cholesterol were among people below the
conventional threshold for defining dyslipidemia (3.37 mmol/l).
The burden of smoking was almost equally distributed among
current and former smokers, because harmful effects continue
among many Americans who have quit smoking. Twenty-nine
percent of the chronic disease mortality effects of alcohol use
occurred among heavy drinkers (i.e., men who consumed more
than 60 grams of pure alcohol or 4 drinks per day and women
who consumed more than 40 grams per day); this group did not
have any mortality benefits from alcohol use. In contrast, in those
who had light alcohol consumption (up to 40 g per day for men
and 20 g per day for women), the protective effects on IHD and
diabetes mortality were larger than the hazardous effects from
other chronic diseases, leading to an overall reduction in mortality
in this group (unpublished results).
Sensitivity Analyses
The results of the sensitivity analyses in Table S1 show that the
estimated numbers of deaths attributable to risk factors were most
sensitive to the choice of the optimal exposure distribution (the
TMRED) to which current risk factor exposure distributions were
compared. For example, if the TMREDs for LDL cholesterol and
BMI were 2.3 (instead of 2.0) mmol/l and 23 (instead of 21) kg/
m
2, respectively, the number of deaths attributable to them would
Figure 1. Deaths attributable to total effects of individual risk factors, by disease. Data are shown for both sexes combined (upper graph);
men (middle graph); and women (lower graph). See Table 8 for 95% CIs. Notes: We used RRs for blood pressure, LDL cholesterol, and FPG that were
adjusted for regression dilution bias using studies that had repeated exposure measurement [7,11,12]; for blood pressure and LDL cholesterol, the
adjusted magnitude is supported by effect sizes from randomized studies [13,14]. Evidence from a large prospective study using multiple
measurements of weight and height showed that regression dilution bias did not affect the RRs for BMI, possibly because there is less variability [15].
RRs for dietary salt and PUFA were from intervention studies, and hence unlikely to be affected by regression dilution bias. RRs for dietary trans fatty
acids were primarily from studies that had used cumulative averaging of repeated measurements [16] that reduces but may not fully correct for
regression dilution bias. RRs for physical inactivity, alcohol use, smoking, and dietary omega-3 fatty acids and fruits and vegetables were not
corrected for regression dilution bias due to insufficient current information from epidemiological studies on exposure measurement error and
variability, which is especially important when error and variability of self-reported exposure may themselves differ across studies. Regression dilution
bias often, although not always, underestimates RRs in multivariate analysis [48].
aThe figures show deaths attributable to the total effects of each
individual risk. There is overlap between the effects of risk factors because of multicausality and because the effects of some risk factors are partly
mediated through other risks. Therefore, the number of deaths attributable to individual risks cannot be added.
bThe effect of high dietary salt on
cardiovascular diseases was estimated through its measured effects on systolic blood pressure.
cThe protective effects of alcohol use on
cardiovascular diseases are its net effects. Regular moderate alcohol use is protective for IHD, ischemic stroke, and diabetes, but any use is hazardous
for hypertensive disease, hemorrhagic stroke, cardiac arrhythmias, and other cardiovascular diseases. NCD, noncommunicable diseases.
doi:10.1371/journal.pmed.1000058.g001
Table 8. Deaths from all causes (thousands of deaths) attributable to risk factors and the 95% confidence intervals of their
sampling uncertainty.
Risk factor Male Female Both Sexes
Tobacco smoking 248 (226–269) 219 (196–244) 467 (436–500)
High blood pressure 164 (153–175) 231 (213–249) 395 (372–414)
Overweight–obesity (high BMI) 114 (95–128) 102 (80–119) 216 (188–237)
Physical inactivity 88 (72–105) 103 (80–128) 191 (164–222)
High blood glucose 102 (80–122) 89 (69–108) 190 (163–217)
High LDL cholesterol 60 (42–70) 53 (44–59) 113 (94–124)
High dietary salt (sodium) 49 (46–51) 54 (50–57) 102 (97–107)
Low dietary omega-3 fatty acids (seafood) 45 (37–52) 39 (31–47) 84 (72–96)
High dietary trans fatty acids 46 (33–58) 35 (23–46) 82 (63–97)
Alcohol use
a 45 (32–49) 20 (17–22) 64 (51–69)
Low intake of fruits and vegetables 33 (23–45) 24 (15–36) 58 (44–74)
Low dietary polyunsaturated fatty acids (PUFA) (in replacement of SFA) 9 (6–12) 6 (3–9) 15 (11–20)
aExcludes uncertainty in intentional and unintentional injury outcomes because the attributable deaths used data sources that did not report sampling uncertainty.
doi:10.1371/journal.pmed.1000058.t008
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physical activity to the (less ambitious) current recommended level
of 600 met?min per week (equivalent to 20 min of moderate
activity every day) would prevent 62,000 (32%) fewer deaths than
if people pursued a higher goal of 1,600 met?min per week
(including at least one hour of vigorous activity per day). The
TMRED for alcohol use must balance its harmful and beneficial
effects. If the entire adult US population had light alcohol
Table 9. Distribution of cause-specific and all-cause deaths attributable to risk factors by age group and by sex.
Risk Factor Disease 0–29 y 30–45 y 45–69 y $ 70 y Males Females
High blood glucose Cardiovascular diseases NA 2 (1 to 3) 31 (24 to 40) 68 (58 to 75) 55 (43 to 68) 45 (32 to 57)
Diabetes mellitus
a NA 3 (3 to 3) 33 (33 to 33) 64 (64 to 64) 51 (51 to 51) 49 (49 to 49)
Renal failure NA 1 (0 to 6) 21 (3 to 71) 77 (26 to 96) 53 (12 to 94) 47 (6 to 88)
All causes NA 2 (2 to 3) 31 (26 to 36) 67 (61 to 72) 53 (46 to 61) 47 (39 to 54)
High LDL cholesterol Cardiovascular diseases NA 4 (0 to 6) 40 (30 to 47) 55 (50 to 66) 53 (44 to 59) 47 (41 to 56)
High blood pressure Cardiovascular diseases NA 1 (1 to 1) 19 (18 to 20) 80 (79 to 82) 42 (39 to 44) 58 (56 to 61)
Overweight–obesity (high
BMI)
Cardiovascular diseases NA 5 (3 to 6) 41 (33 to 48) 55 (47 to 63) 55 (47 to 65) 45 (35 to 53)
Cancers NA 2 (2 to 3) 42 (38 to 47) 55 (51 to 60) 40 (36 to 46) 60 (54 to 64)
Diabetes mellitus NA 5 (4 to 5) 42 (38 to 47) 54 (48 to 58) 52 (46 to 58) 48 (42 to 54)
All causes NA 4 (3 to 5) 41 (36 to 46) 55 (49 to 61) 53 (47 to 60) 47 (40 to 53)
High dietary trans fatty
acids
Cardiovascular diseases NA 5 (3 to 7) 41 (31 to 50) 54 (45 to 65) 57 (46 to 67) 43 (33 to 54)
Low dietary
polyunsaturated fatty
acids (PUFA)
(in replacement of SFA)
Cardiovascular diseases NA 7 (2 to 11) 40 (23 to 56) 53 (37 to 70) 59 (43 to 75) 41 (25 to 57)
Low dietary omega-3
fatty acids
Cardiovascular diseases NA 4 (3, 5) 36 (30 to 41) 60 (54 to 66) 53 (47 to 60) 47 (40 to 53)
High dietary salt Cardiovascular diseases NA 3 (3 to 3) 28 (27 to 30) 69 (67 to 70) 47 (45 to 50) 53 (50 to 55)
Cancers NA 5 (1 to 8) 36 (21 to 52) 59 (43 to 74) 58 (40 to 73) 42 (27 to 60)
All causes NA 3 (3 to 3) 29 (27 to 30) 68 (66 to 70) 48 (45 to 50) 52 (50 to 55)
Low intake of fruits and
vegetables
Cardiovascular diseases NA 3 (1 to 5) 35 (22 to 52) 62 (44 to 75) 55 (37 to 76) 45 (24 to 63)
Cancers NA 3 (2 to 5) 56 (39 to 71) 41 (25 to 58) 62 (47 to 76) 38 (24 to 53)
All causes NA 3 (2 to 5) 43 (32 to 57) 54 (39 to 66) 58 (45 to 71) 42 (29 to 55)
Alcohol use
b Cardiovascular diseases NA 11 (4 to 34) 131 (93 to 159) 242 (275 to
27)
105 (85 to 126) 25( 226 to 15)
Cancers NA 5 (4 to 6) 55 (49 to 61) 40 (34 to 46) 64 (58 to 69) 36 (31 to 42)
Diabetes mellitus NA 5 (4 to 6) 44 (40 to 49) 51 (46 to 55) 50 (45 to 55) 50 (45 to 55)
Other noncommunicable
diseases
c
NA 15 (14 to 16) 68 (66 to 71) 17 (15 to 19) 74 (72 to 76) 26 (24 to 28)
Injuries
d 31 (31 to 31) 34 (34 to 34) 29 (29 to 29) 6 (6 to 6) 77 (77 to 77) 23 (23 to 23)
All causes 18 (16 to 23) 24 (21 to 30) 34 (20 to 40) 24 (20 to 30) 70 (62 to 73) 30 (27 to 38)
Physical inactivity Cardiovascular diseases NA 2 (1 to 2) 24 (19 to 30) 74 (68 to 79) 49 (40 to 60) 51 (40 to 60)
Cancers NA 5 (3 to 7) 42 (35 to 50) 53 (45 to 60) 24 (18 to 29) 76 (71 to 82)
Diabetes mellitus NA 3 (2 to 5) 35 (28 to 43) 61 (52 to 69) 50 (40 to 61) 50 (39 to 60)
All causes NA 2 (2 to 3) 28 (23 to 33) 70 (64 to 75) 46 (38 to 54) 54 (46 to 62)
Tobacco smoking Cardiovascular diseases NA 4 (0 to 7) 51 (43 to 63) 44 (34 to 54) 49 (38 to 60) 51 (40 to 62)
Cancers NA 1 (0 to 2) 43 (42 to 44) 56 (55 to 57) 61 (60 to 62) 39 (38 to 40)
Other respiratory diseases
e NA 0 (0 to 1) 21 (19 to 22) 79 (78 to 80) 46 (44 to 48) 54 (52 to 56)
Diabetes mellitus NA 1 (0 to 3) 36 (30 to 41) 63 (57 to 68) 50 (44 to 57) 50 (43 to 56)
All causes NA 2 (0 to 3) 39 (36 to 42) 59 (56 to 62) 53 (49 to 57) 47 (43 to 51)
Numbers show percent in each age group or in each sex and the corresponding 95% confidence intervals of sampling uncertainty.
aThere is no sampling uncertainty for this outcome because all the deaths due to diabetes are by definition attributable to high blood glucose.
bThe negative proportions for alcohol use and cardiovascular diseases in older ages and in females occur because the protective effects are larger than the hazardous
effects.
cThis category includes liver cirrhosis, acute and chronic pancreatitis, and alcohol use disorders.
dWe did not estimate sampling uncertainty for injury outcomes because the attributable deaths used data sources that did not report sampling uncertainty.
eThis category includes lower respiratory tract infections, asthma, and tuberculosis.
doi:10.1371/journal.pmed.1000058.t009
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both sexes combined (upper graph); men (middle graph); and women (lower graph). See Figure 1 notes.
doi:10.1371/journal.pmed.1000058.g002
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prevented, largely among adults aged $45 y. However, this level
of alcohol consumption would also cause an estimated 8,000
deaths due to road traffic accidents largely among adults aged
,30 y.
Incorporating correlation of a risk factor with disease-specific
mortality and with other risks changed the estimated number of
deaths attributable to a risk factor by 3%–31%, depending on the
specific risk factor and disease. The results were robust to whether
exposure in the population was approximated with a normal
distribution and to the inclusion of the few disease outcomes for
which the evidence of causal association was weaker. Mortality
effects of dietary salt were sensitive to the magnitude of its effects
on SBP, because there was an almost 2-fold difference between
two separate meta-analyses of salt reduction trials [37,38].
Discussion
Ouranalysisof the mortalityeffects ofmajordietary,lifestyle, and
metabolic risk factors in the US using comparable methods showed
that tobacco smoking and high blood pressure were the leading risk
factors for mortality, responsible for nearly one in five and one in six
deaths in US adults, respectively. The large effects of tobacco
smoking were caused by long-term cumulative exposure in current
smokers as well as the remaining effects in former smokers,
especially in men. The large numbers of deaths attributable to high
blood pressure were related to high exposure levels, particularly in
women [39]. Overweight–obesity, physical inactivity, and high
blood glucose each caused about one in ten deaths, and both
affected women disproportionately more than men. In those
younger than 70 y of age, tobacco smoking was by far the leading
modifiable cause of death, and overweight–obesity caused more
deaths than did high blood pressure. Other lifestyle, metabolic, and
dietary risk factors for chronic diseases also caused significant adult
mortality,althoughtheirindividual effectswere 3%–24%ofthoseof
smoking. A comparison of our results with those of other risk factors
is shown in Table S2. This comparison was done only for those risk
factors included in previous analyses, because these analyses had
included substantially fewer metabolic and dietary risks than ours.
Each RR used in our analysis represents the best evidence for
the impact of risk factor exposure on disease-specific mortality in
the population, based on the current causes and determinants of
Table 10. Distribution of risk factor exposure and attributable deaths by ranges or categories of exposure defined using common
clinical and public health thresholds and guidelines.
Risk Factor Source of Definition for Categories Exposure Categories
Percentage of
Attributable
Deaths
Percentage of
Population
($30 Years Old)
High blood glucose
a Definition of diabetes (FPG$7 mmol/l) and impaired
FPG (FPG 5.56 to 6.99 mmol/l) by American Diabetes
Association [103]
FPG$7 mmol/l 60 10
FPG 5.56–6.99 mmol/l 34 29
FPG,5.56 mmol/l 6 61
High LDL cholesterol Definition of high LDL cholesterol in low risk
(4.14 mmol/l) and moderate risk (3.37 mmol/l) individuals
in Adult Treatment Panel III guidelines [104]
LDL$4.14 mmol/l 5 11
LDL 3.37–4.13 mmol/l 30 22
LDL,3.37 mmol/l 65 67
High blood pressure Definition of hypertension (SBP$140 mmHg) [105] SBP$140 mmHg 66 15
SBP,140 mmHg 34 85
Overweight–obesity
(high BMI)
Definition of obesity (BMI$30 kg/m
2) and overweight
(BMI 25 to 29.9 kg/m
2)
BMI$30 kg/m
2 63 33
BMI 25–29.9 kg/m
2 29 33
BMI,25 kg/m
2 83 3
High dietary salt Recommended level of dietary sodium (,100 mmol/d)
by American Heart Association [106]
Dietary sodium$100 mmol/d 88 75
Dietary sodium,100 mmol/d 12 25
Physical inactivity Definition of moderately active (600 met?min/wk) is the
same as the recommended level of activity by Centers
for Disease Control and Prevention [107]
Inactive 74 31
Low-active 19 25
Moderately active 7 23
Highly active 0 21
Tobacco smoking — Current smokers 43 25
Former smokers 57 25
Never smokers 0 50
The proportion of population and mortality effects in different exposure categories. We have not included dietary risks other than dietary salt in this table primarily
because current guidelines do not recommend a specific level of intake.
aDeaths assigned to diabetes mellitus in the vital statistics and deaths attributable to renal failure are included in the $7 mmol/l category because all individuals whose
deaths are assigned to diabetes or diabetic renal failure would, by definition, have been diagnosed with diabetes disease, and hence have FPG $7 mmol/l.
doi:10.1371/journal.pmed.1000058.t010
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risk factor may depend on whether an expected increase in
exposure is prevented or whether exposure is reduced after it has
risen. It may also depend on the specific intervention used to
prevent or reverse risk factor exposure. The estimated effects of
blood pressure, LDL cholesterol, omega-3 fatty acids, and PUFA-
SFA replacement have been generally consistent between
observational studies that measure exposure at baseline and
intervention studies that reduce exposure prospectively [12,14,31].
There is also evidence that former smokers reduce their risk to that
of never-smokers over time [40]. Although mortality effects of
other risks in our analysis have not been tested in appropriately
designed and powered intervention studies, trials and observa-
tional studies provide similarly valid results on related nonfatal
events for some risks, e.g., effects of BMI on incident diabetes
[41,42]. Possibly the most important case of current discrepancy
between prospective observational cohorts and intervention studies
is the mortality effect of high blood glucose. Prospective studies
have shown relatively large associations between usual FPG and
mortality [7,43], but randomized intervention studies have shown
null effects, and declines as well as increases in mortality when
glucose was lowered intensively relative to those who had
conventional management [44,45]. This discrepancy may reflect
the actual intervention mechanism (lifestyle versus pharmacologic
treatment) or the differential effects of avoiding an increase in
blood glucose versus subsequent lowering. Alternatively, blood
glucose may be a partial or confounded marker of other
underlying metabolic dysfunction, so that interventions targeting
only glucose may be unsuccessful at ameliorating all of the
observed risk. Further research is needed on the causal effects of
blood glucose on mortality risk and on the role of specific lifestyle
and pharmacologic interventions. Finally, there is also a need to
systematically examine whether salt reduction trials with suffi-
ciently long follow-up duration can capture the full blood
pressure–lowering benefits of having maintained low salt intake
throughout the life course [37].
Our results estimate the total effects of each individual risk
factor. Disease-specific deaths are caused by multiple factors acting
simultaneously, and hence could be prevented by intervening on
single or multiple risk factors, e.g., some IHD deaths may be
prevented by reducing SBP, LDL cholesterol, smoking, or
combinations of these risks [46]. Further, part of the effect of
one risk factor may be mediated through another, e.g., dietary
factors and physical inactivity may affect IHD with part of their
effect occurring by changes in BMI, blood pressure, glucose, and
LDL cholesterol. Deaths attributable to multiple causally related
or overlapping risk factors should not be combined by simple
addition. Future analyses, both in epidemiological cohorts and at
the population level, should examine the individual and combined
effects of multiple exposures that affect the same diseases,
including how much of the effects of lifestyle and dietary risks
are mediated through metabolic factors. Finally, the effects of
dietary macronutrients may vary depending on the macronutrient
replacement (e.g., for PUFA; see Table 2 for details). Therefore,
the interpretation of results should take such replacement issues
into account.
There are a number of innovations and strengths in our
analysis. This is, to our knowledge, the first population-level
analysis of the mortality effects of risk factors to include a relatively
large number of dietary and metabolic risk factors, and to use
consistent and comparable methods. This comparative quantifi-
cation helped identify the important roles of diet and physical
inactivity, other lifestyle factors, and metabolic risks as preventable
causes of death in the US population. Effect sizes were derived
from large meta-analyses of either randomized trials or observa-
tional studies that had adjusted for important confounders. RRs
from meta-analyses tend to reduce random error relative to
individual studies; they may also reduce bias if the directions of
bias are not the same in individual studies. We used exposure
distributions and effect sizes that accounted for measurement error
associated with one-off measurements to the extent possible. Our
study presented deaths attributable to risk factors by age and sex,
and by exposure level. The latter helped identify whether those
whose exposure remains uncontrolled with current diagnosis and
treatment programs versus those who are currently below clinical
thresholds should be targeted for greatest effects on mortality.
Finally, we quantified the sampling uncertainty of our estimates;
we also analyzed how specific methods and data sources affected
our quantitative results in extensive sensitivity analyses. This
demonstrated that although the specific numerical results are
uncertain, our overall findings on the relative mortality effects of
these dietary, lifestyle, and metabolic risk factors are robust.
Population level analyses of mortality effects of risk factors such
as ours are also affected by some limitations and uncertainties.
First, several potentially important risk factors were considered,
but could not be included because sufficient or unbiased data on
their national exposure distributions and/or effects on disease-
specific mortality were not available, or because the evidence on
causal effects was less convincing. Second, for many risks the
choice of disease outcomes and effect sizes were derived from
observational studies. In such cases, whether the collectivity of
evidence established a causal association had to be assessed using
multiple criteria, such as those proposed by Hill [47]. In such
cases, the possibility of residual confounding cannot be excluded.
Our ability to account for measurement error in exposure and to
correct for regression dilution bias was limited to those risk factors
for which relevant data were available from epidemiological
studies; for other risks, our results should be considered as
conservative estimates of the effects because regression dilution
bias often, although not always, leads to lower RRs in multivariate
analysis [48]. RRs from meta-analyses may not be completely
generalizable to population-level effects; nevertheless, such esti-
mation is indispensable to inform policy making. More impor-
tantly, in many cases there is empirical evidence to support the
proposition that proportional effects are similar across populations,
e.g., Western and Asian populations [7,20,21].
The hazardous effects of some risk factors accumulate gradually
after exposure begins and decline slowly after exposure is reduced.
This is illustrated by results from trials that have lowered blood
pressure and cholesterol, and from studies in which some people
quit smoking [13,40]. Time-dependence of risk may further vary
by disease, e.g., the effects of tobacco smoking on lung cancer
versus cardiovascular diseases [49]. Because smoking prevalence
has declined in the US, the use of the smoking impact ratio (SIR)
as the metric of cumulative exposure [18] may have overestimated
the cardiovascular deaths attributable to smoking. However, the
difference between the estimated number of deaths using this
method and using the measured prevalence of current and former
smoking was ,14% (Table S1). The use of RRs from cohort
studies that started a few decades ago may overestimate the effects
of BMI on diseases such as IHD if ‘‘mediators’’ such as SBP and
cholesterol have been lowered over time in those with high BMI
[50–52], but underestimate the effects for other diseases such as
diabetes because the current US population gained weight at
younger ages than the cohort participants. Future research should
attempt to investigate time-dependent effects of blood glucose,
BMI, physical activity, and dietary factors, because their exposures
have changed in the US over time.
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factors show that targeting a handful of risk factors has large
potential to reduce mortality in the US, substantially more than
the currently estimated 18,000 deaths averted annually by
providing universal health insurance [53]. Global analyses also
found that a relatively modest number of risk factors were
responsible for a substantial proportion of mortality and disease
burden in many world regions. At the same time the mix of
leading risks varied across regions, as did risk factor levels in
relation to economic development and urbanization [46,54].
Therefore there is a need for national, and even subnational,
analysis of the health consequences of these risks in countries at
different levels of development using local exposure data [55].
The risk factors in this analysis can be influenced through both
individual-level and population-wide interventions. In particular,
effective interventions are available for tobacco smoking and high
blood pressure, the leading two causes of mortality in the US [56–
58]. Combinations of food industry regulation, pricing, and better
information can also be effective in reducing exposure to dietary
salt and trans fatty acids, especially in packaged foods and
prepared meals. Despite the availability of interventions, blood
pressure and tobacco smoking decline in the US have stagnated or
even reversed [39,59], and there has been a steady increase in
overweight–obesity [60]. Research, implementation, monitoring,
and evaluation related to interventions that reduce these
modifiable risk factors should be a high priority.
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Background. A number of modifiable factors are
responsible for many premature or preventable deaths. For
example, being overweight or obese shortens life
expectancy, while half of all long-term tobacco smokers in
Western populations will die prematurely from a disease
directly related to smoking. Modifiable risk factors fall into
three main groups. First, there are lifestyle risk factors. These
include tobacco smoking, physical inactivity, and excessive
alcohol use (small amounts of alcohol may actually prevent
diabetes and some types of heart disease and stroke).
Second, there are dietary risk factors such as a high salt
intake and a low intake of fruits and vegetables. Finally, there
are ‘‘metabolic risk factors,’’ which shorten life expectancy by
increasing a person’s chances of developing cardiovascular
disease (in particular, heart problems and strokes) and
diabetes. Metabolic risk factors include having high blood
pressure or blood cholesterol and being overweight or
obese.
Why Was This Study Done? It should be possible to
reduce preventable deaths by changing modifiable risk
factors through introducing public health policies, programs
and regulations that reduce exposures to these risk factors.
However, it is important to know how many deaths are
caused by each risk factor before developing policies and
programs that aim to improve a nation’s health. Although
previous studies have provided some information on the
numbers of premature deaths caused by modifiable risk
factors, there are two problems with these studies. First, they
have not used consistent and comparable methods to
estimate the number of deaths attributable to different risk
factors. Second, they have rarely considered the effects of
dietary and metabolic risk factors. In this new study, the
researchers estimate the number of deaths due to 12
different modifiable dietary, lifestyle, and metabolic risk
factors for the United States population. They use a method
called ‘‘comparative risk assessment.’’ This approach
estimates the number of deaths that would be prevented
if current distributions of risk factor exposures were changed
to hypothetical optimal distributions.
What Did the Researchers Do and Find? The researchers
extracted data on exposures to these 12 selected risk factors
from US national health surveys, and they obtained
information on deaths from difference diseases for 2005
from the US National Center for Health Statistics. They used
previously published studies to estimate how much each risk
factor increases the risk of death from each disease. The
researchers then used a mathematical formula to estimate
the numbers of deaths caused by each risk factor. Of the 2.5
million US deaths in 2005, they estimate that nearly half a
million were associated with tobacco smoking and about
400,000 were associated with high blood pressure. These
two risk factors therefore each accounted for about 1 in 5
deaths in US adults. Overweight–obesity and physical
inactivity were each responsible for nearly 1 in 10 deaths.
Among the dietary factors examined, high dietary salt intake
had the largest effect, being responsible for 4% of deaths in
adults. Finally, while alcohol use prevented 26,000 deaths
from ischemic heart disease, ischemic stroke, and diabetes,
the researchers estimate that it caused 90,000 deaths from
other types of cardiovascular diseases, other medical
conditions, and road traffic accidents and violence.
What Do These Findings Mean? These findings indicate
that smoking and high blood pressure are responsible for
the largest number of preventable deaths in the US, but that
several other modifiable risk factors also cause many deaths.
Although the accuracy of some of the estimates obtained in
this study will be affected by the quality of the data used,
these findings suggest that targeting a handful of risk factors
could greatly reduce premature mortality in the US. The
findings might also apply to other countries, although the
risk factors responsible for most preventable deaths may
vary between countries. Importantly, effective individual-
level and population-wide interventions are already available
to reduce people’s exposure to the two risk factors
responsible for most preventable deaths in the US. The
researchers also suggest that combinations of regulation,
pricing, and education have the potential to reduce the
exposure of US residents to other risk factors that are likely
to shorten their lives.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000058.
N The MedlinePlus encyclopedia contains a page on healthy
living (in English and Spanish)
N The US Centers for Disease Control and Prevention
provides information on all aspects of healthy living
N Healthy People 2010 is a national framework designed to
improve the health of people living in the US. The Healthy
People 2020 Framework is due to be launched in January
2010
N The World Health Report 2002—Reducing Risks, Promot-
ing Healthy Life provides a global analysis of how healthy
life expectancy could be increased
N The National Health and Nutrition Examination Survey
(NHANES) is ‘‘a program of studies designed to assess the
health and nutritional status of adults and children in the
United States’’
N The US Centers for Disease Control and Prevention’s site
Smoking and Tobacco Use offers a large number of
informational and data resources on this important risk
factor
N The American Heart Association and American Cancer
Society provide a rich resource for patients and caregivers
on many important risk factors including diet, sodium
intake, and smoking
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